drugset / Trial / NCT01648491

Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use

NCT01648491

NaSingle-groupOpen-labelTreatment

Summary

Determine safety and effectiveness of the technique using autologous stem cells in the treatment of urinary incontinence in one male subject.

Timeline

Start
2011-10
Primary completion
2012-07
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Stem Cells Cell therapy Other